{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:34:24Z","timestamp":1791513264760,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00431-021-03990-8","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T10:05:34Z","timestamp":1613729134000},"page":"2075-2081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Variables related to chronic immune thrombocytopenia: experience from a single center and comparison to a meta-analysis"],"prefix":"10.1007","volume":"180","author":[{"given":"S.","family":"Fern\u00e1ndez-Plaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez de Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2330-8257","authenticated-orcid":false,"given":"E.","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4115-9598","authenticated-orcid":false,"given":"J.","family":"Zubicaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6852-1860","authenticated-orcid":false,"given":"J.","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5444-8076","authenticated-orcid":false,"given":"E.","family":"Sebasti\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"3990_CR1","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, K\u00fchne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386\u20132393","journal-title":"Blood"},{"key":"3990_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1067\/S0022-3476(03)00535-3","volume":"143","author":"T K\u00fchne","year":"2003","unstructured":"K\u00fchne T, Buchanan G, Zimmerman S, Michaels LA, Kohan R, Berchtold W, Imbach P, Intercontinental Childhood ITP Study Group, Intercontinental Childhood ITP Study Group (2003) A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 143:605\u2013608","journal-title":"J Pediatr"},{"key":"3990_CR3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/pbc.24628","volume":"60","author":"M Deel","year":"2013","unstructured":"Deel M, Kong M, Cross K, Bertolone S (2013) Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children. Pediatr Blood Cancer 60:1967\u20131974","journal-title":"Pediatr Blood Cancer"},{"key":"3990_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jpeds.2013.06.018","volume":"163","author":"Revel","year":"2013","unstructured":"Revel, Vilk S, Yacobovich J et al (2013) Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months. J Pediatr 163:1335\u20131339.e1-2","journal-title":"J Pediatr"},{"key":"3990_CR5","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1542\/peds.2007-1129","volume":"121","author":"M Glanz","year":"2008","unstructured":"Glanz M, France E, Xu S et al (2008) A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 121:e506\u2013e512","journal-title":"Pediatrics"},{"key":"3990_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.2004.05235.x","volume":"127","author":"M Bruin","year":"2004","unstructured":"Bruin M, Bierings M, Uiterwaal C, R\u00e9v\u00e9sz T, Bode L, Wiesman ME, Kuijpers T, Tamminga R, de Haas M (2004) Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study. Br J Haematol 127:561\u2013567","journal-title":"Br J Haematol"},{"key":"3990_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/pbc.21872","volume":"52","author":"H Donato","year":"2009","unstructured":"Donato H, Pic\u00f3n A, Martinez M, Rapetti MC, Rosso A, Gomez S, Rossi N, Bacciedoni V, Schvartzman G, Riccheri C, Costa A, di Santo J (2009) Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicenter study from Argentina. Pediatr Blood Cancer 52:491\u2013496","journal-title":"Pediatr Blood Cancer"},{"key":"3990_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/pbc.22570","volume":"55","author":"I Ahmed","year":"2010","unstructured":"Ahmed I, Rajpurkar M, Thomas R, Chitlur M (2010) Initial lymphocyte count and the development of persistent\/chronic immune thrombocytopenic purpura. Pediatr Blood Cancer 55:508\u2013511","journal-title":"Pediatr Blood Cancer"},{"key":"3990_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11239-007-0031-y","volume":"24","author":"A Altintas","year":"2007","unstructured":"Altintas A, Ozel A, Okur N, Okur N, Cil T, Pasa S, Ayyildiz O (2007) Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 24:163\u2013168","journal-title":"J Thromb Thrombolysis"},{"key":"3990_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2141.2009.07743.x","volume":"146","author":"R Tamminga","year":"2009","unstructured":"Tamminga R, Berchtold W, Bruin M, Buchanan GR, K\u00fchne T (2009) Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS). Br J Haematol 146:180\u2013184","journal-title":"Br J Haematol"},{"key":"3990_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2141.2007.06682.x","volume":"138","author":"P Edslev","year":"2007","unstructured":"Edslev P, Rosth\u00f8j S, Treutiger I et al (2007) NOPHO ITP Working Group. A clinical score predicting a brief and uneventful course of newly diagnosed idiopathic thrombocytopenic purpura in children. Br J Haematol 138:513\u2013516","journal-title":"Br J Haematol"},{"key":"3990_CR12","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1182\/blood-2014-04-570127","volume":"124","author":"KMJ Heitink-Poll\u00e9","year":"2014","unstructured":"Heitink-Poll\u00e9 KMJ, Nijsten J, Boonacker C et al (2014) Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood 124:3295\u20133307","journal-title":"Blood"},{"key":"3990_CR13","first-page":"623","volume":"44","author":"MA Dasi","year":"1996","unstructured":"Dasi MA, D\u00edaz C, Fern\u00e1ndez-Delgado R, Monteagudo E, Repiso R, Sastre A, Toll T (1996) Protocol for the study and treatment of immune thrombocytopenic purpura. An Esp Pediatr 44:623\u2013631","journal-title":"An Esp Pediatr"},{"key":"3990_CR14","doi-asserted-by":"publisher","first-page":"414.e1-8","DOI":"10.1016\/j.anpedi.2010.09.009","volume":"74","author":"E Monteagudo","year":"2011","unstructured":"Monteagudo E, Fern\u00e1ndez-Delgado R, Sastre A, Toll T, Llort A, Molina J et al (2011) Protocol for the study and treatment of immune thrombocytopenic purpura (ITP). ITP-2010. An Pediatr (Barc) 74:414.e1-8","journal-title":"An Pediatr (Barc)"},{"key":"3990_CR15","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 117:4190\u20134207","journal-title":"Blood."},{"issue":"5","key":"3990_CR16","first-page":"396","volume":"18","author":"E Parodi","year":"2020","unstructured":"Emilia Parodi, Giovanna Russo, Piero Farruggia, Lucia D Notarangelo, Maria T Giraudo, Margherita Nardi, Fiorina Giona, Paola Giordano, Ugo Ramenghi, \u201cAIEOP-ITP Study Group\u201d, et al. Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study. Blood Transfus 2020;18(5):396-405.","journal-title":"Blood Transfus"},{"issue":"7","key":"3990_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1080\/08880010903044540","volume":"26","author":"F Demircioglu","year":"2009","unstructured":"Demircioglu F, Saygi M, Yilmaz S, Oren H, Irken G (2009) Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 26(7):526\u2013532","journal-title":"Pediatr Hematol Oncol"},{"key":"3990_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1182\/blood-2018-02-830844","volume":"132","author":"KMJ Heitink-Poll\u00e9","year":"2018","unstructured":"Heitink-Poll\u00e9 KMJ, Uiterwaal CSPM, Porcelijn L, Tamminga RYJ, Smiers FJ, van Woerden N, Wesseling J, Vidarsson G, Laarhoven AG, de Haas M, Bruin MCA, TIKI Investigators (2018) Intravenous immunoglobulin versus observation in childhood immune thrombocytopenia: a randomized controlled trial. Blood. 132:883\u2013891","journal-title":"Blood."}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-03990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-03990-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-03990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T14:03:25Z","timestamp":1623420205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-03990-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3990"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-03990-8","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was evaluated by the local Ethics Committee. This study was approved by the research ethics committee of the Hospital Infantil Universitario Ni\u00f1o Jes\u00fas (Registration number: R-0042\/16). Given the retrospective nature of the study, and that all the procedures performed were part of routine care, it was not considered necessary to request new informed consents, providing all information is anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, consent to participate, and consent for publication"}},{"value":"Julian Sevilla: consultant\/advisor\/honorarium (Amgen, Novartis, Miltenyi, Sobi, Rocket Pharma). Elena Sebastian: honorarium (Novartis), Josune Zubicaray: honorarium (Novartis). Eva G\u00e1lvez: honorarium (Novartis). The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}